in this issue
Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Covidien reports rise in API sales
8:57 AM MDT | April 29, 2013 | Deepti Ramesh
The active pharmaceutical ingredient (API) business of Covidien (Dublin) report an 11.4% rise in sales in the company’s second quarter, ended 29 March, compared with the year-ago quarter, to $127 million. Sales of APIs were considerably higher than the previous year, largely attributable to a substantial increase in sales of narcotic API products, Covidien says. During the 6-month period ended 29 March, the API business reported a 1.8% rise in sales compared with the corresponding period of the previous fiscal year, to $220...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee